Pitx2 is a newly described bicoid-like homeodomain transcription factor tha
t is defective in Rieger syndrome and shows a striking leftward development
al asymmetry. We have previously shown that Pitx2 (also called Ptx2 and RIE
G) transactivates a reporter gene containing a bicoid enhancer and synergis
tically transactivates the prolactin promoter in the presence of the POU ho
meodomain protein Pit-1. In this report, we focused on the C-terminal regio
n which is mutated in some Rieger patients and contains a highly conserved
14-amino-acid element. Deletion analysis of Pitx2 revealed that the C-termi
nal 39-amino-acid tail represses DNA binding activity and is required for P
itx2-Pit-1 interaction and Pit-1 synergism. Pit-1 interaction with the Pitx
2 C terminus masks the inhibitory effect and promotes increased DNA binding
activity. Interestingly, cotransfection of an expression vector encoding t
he C-terminal 39 amino acids of Pitx2 specifically inhibits Pitx2 transacti
vation activity. In contrast, the C-terminal 39-amino-acid peptide interact
s with Pitx2 to increase its DNA binding activity. These data suggest that
the C-terminal tail intrinsically inhibits the Pitx2 protein and that this
inhibition can be overcome by interaction with other transcription factors
to allow activation during development.